Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2016-03-01 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于对葵花药业集团（吉林）临江有限公司实施财务资助公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the provision of financial support by the parent company to its subsidiary. It details the amount, purpose, terms, and approval process of the financial assistance. The document includes information about the subsidiary, risk control measures, and independent directors' opinions. It is not a financial report, earnings release, or management discussion but rather a specific update on financing activity within the corporate group. The document length is about 2,064 characters, which is relatively short and focused on a financing event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2016-03-01 Chinese
关于聘任高级管理人员公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel (Mr. Wan Yunguo) as the company's vice general manager. It includes details about his background, qualifications, and compliance with legal requirements. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the appointment. The document is clearly about management changes, specifically the hiring of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this announcement, confirming it is not a full report or other filing type.
2016-03-01 Chinese
第二届董事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company 葵花药业集团股份有限公司. It details the appointment of a senior management member, approval of acquisition and capital injection proposals, and financial support to a subsidiary. The document includes voting results and mentions independent directors' opinions. It is not a full annual or interim report, nor a financial statement. It is not a call transcript, earnings release, or regulatory filing of another type. The content clearly relates to board decisions and management appointments, which fits the category of Board/Management Information (MANG). The document length is short (1485 characters), and it is a meeting resolution announcement, not a report publication or certification. Therefore, the classification is MANG with high confidence.
2016-03-01 Chinese
2015年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2015 年度业绩快报" which translates to "2015 Annual Performance Express Report" or "2015 Annual Earnings Quick Report." It contains preliminary financial data for the full year 2015, including revenue, profit, net profit attributable to shareholders, earnings per share, and return on equity. The data is described as preliminary and unaudited, with a caution that final audited figures may differ. The document also includes a management discussion explaining the financial results and factors affecting performance. The length of the document is about 2065 characters, which is relatively short and suggests it is a brief earnings announcement rather than a full annual report. The document does not contain full audited financial statements or comprehensive disclosures typical of a 10-K or full Annual Report. Instead, it provides key financial highlights and a brief explanation of results, consistent with an Earnings Release (ER). Therefore, the document should be classified as an Earnings Release (ER). FY 2015
2016-02-26 Chinese
关于子公司收到工艺技术改造资金的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (376 characters) about a subsidiary receiving industrial technology transformation funds. It states the amount received and accounting treatment but does not contain financial statements or detailed financial data. It is an announcement of a specific event related to financing or capital but not a full financing update or capital structure change. Given the brevity and nature, it fits best as a Regulatory Filing (RNS) since it does not meet criteria for Capital/Financing Update (CAP) or other categories and is not a report or detailed financial document.
2016-01-29 Chinese
第二届董事会第二十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 26th meeting of the second board of directors of the company. It includes details about the approval of capital increase for a subsidiary and the appointment of a senior management member. The document contains voting results and references to meeting procedures and independent director opinions. It does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and focused on board decisions, not a full report or regulatory filing. Therefore, the classification is MANG with high confidence.
2015-12-29 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.